Grown Rogue International (GRUSF) Cash from Investing Activities Growth (3y) (2014 - 2023)
Grown Rogue International (GRUSF) Cash from Investing Activities Growth (3y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 8.16% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 26.15% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 51.85% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 75.05% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 33.33% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -129.09% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -2.94% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -17.64% |
| Jul 31, 2023 | -91.16% |
| Apr 30, 2023 | -42.98% |
| Jan 31, 2023 | -81.27% |
| Jan 31, 2022 | -77.43% |
| Oct 31, 2021 | -10,911.87% |
| Jul 31, 2021 | -229.34% |
| Apr 30, 2021 | 142.96% |
| Jan 31, 2021 | 40.66% |
| May 31, 2017 | 82.04% |
| Nov 30, 2016 | -3.85% |
| Nov 30, 2014 | 12.40% |